Boehringer Ingelheim Vietnam LLC| Boehringer Ingelheim Animal Health Vietnam LLC


Address: HCMC Office: M Plaza, 14th Floor, Unit 04-09, Le Duan, District 1, HCMC, Vietnam| Hanoi Office: Lotte Center Hanoi, 26th Floor, Unit 2603, East Tower 54 Lieu Giai Street, Ba Dinh District, Hanoi City

Telephone: HCMC: +84 28 3823 6919 | Hanoi: +84 24 3562 4130

Fax: HCMC: +84 28 3823 6916 | Hanoi: +84 24 3562 4139



Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need.

Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

In 2021, Boehringer Ingelheim stepped up annual investments in R&D to a new high in history. The company spent 4.1 billion EUR on R&D. Boehringer Ingelheim recorded net sales of 20.6 billion EUR (2020: 19.6 billion EUR), a 5.4% increase compared to the previous year.

Under the ‘Sustainable Development – For Generations’ framework, Boehringer Ingelheim has globally pledged 250 million EUR to combat infectious diseases in humans and animals and expanding healthcare access for non-communicable diseases for 50 million people in vulnerable communities, including in the ASKAN area. In addition to improving across-the-board access to healthcare, Boehringer Ingelheim is committed to carbon neutrality by 2030 and is taking bold steps to address the growing burden of food security and safety to build a sustainable and healthy future for all.

For more information, please visit

Business category: Pharmaceutical/ Animal Health
Employees in Vietnam: approx. 350